Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
96.06%
80%
—
—
40%
—
5 Years
Score—
Net Growth96.06%
Net Trend80%
Net Income Consistency—
Rev Growth—
Rev Trend40%
Revenue Consistency—
BioLineRx Ltd fundamental performance
Across BioLineRx Ltd's full reported history, from 2011 to 2025, revenue declined from $ 63M to $ 1M and net income went from -$ 13M to -$ 1M. Revenue increased in 21% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.69 | — |
1 Year2025-08-12 | $ 3.75 | -28.27% |
5 Years2021-08-12 | $ 120.00 | -97.76% |
10 Years2016-08-12 | $ 510.00 | -99.47% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 |
|---|---|---|---|---|
| Price | $ 2.69 | $ 3.75 | $ 120.00 | $ 510.00 |
| Return | — | -28.27% | -97.76% | -99.47% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 1M | -$ 1M | $ 20M |
| 2024 | $ 28M | -$ 9M | $ 19M |
| 2023 | $ 4M | -$ 60M | $ 42M |
| 2022 | $ 0.00 | -$ 24M | $ 51M |
| 2021 | $ 0.00 | -$ 27M | $ 57M |
| 2020 | $ 0.00 | -$ 30M | $ 22M |
| 2019 | $ 0.00 | -$ 25M | $ 27M |
| 2018 | $ 0.00 | -$ 22M | $ 30M |
| 2017 | $ 0.00 | -$ 24M | $ 49M |
| 2016 | $ 0.00 | -$ 15M | $ 35M |
| 2015 | $ 0.00 | -$ 14M | $ 47M |
| 2014 | $ 0.00 | -$ 10M | $ 34M |
| 2013 | $ 113M | -$ 17M | $ 18M |
| 2012 | $ 113M | -$ 20M | $ 21M |
| IPO2011 | $ 63M | -$ 13M | $ 25M |
Explore beyond BLRX
You're looking at BioLineRx Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
